¥689 7.0 1.0%
Last Trade - 12:10am
| Market Cap | £26.3m |
| Enterprise Value | £22.2m |
| Revenue | £2.24m |
| Position in Universe | 3314th / 3898 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 357.3 | 284.2 | 324.6 | 362.8 | 360.8 | 361.7 | +0.2% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
DNA Chip Research Inc. is primarily engaged in DNA chip-related analysis and next-generation sequence related technology research business, and diagnostic business which is engaged in the sales of medical-related equipment centered on EGFR-NGS Check. The Contract Research segment is engaged in the microarray, next-generation sequencing experiment analysis to universities and research institutes, pharmaceutical and food companies. The Diagnostic segemnt utilizes genetic analysis technology to disseminate tests corresponding to social needs on personalized medicine and undiseased society. The main menu of the diagnostic business is EGFR-NGS Check. The Research and Development segment includes research on cancer diagnosis technology using next generation sequencer, as well as the development of RNA check.
| Last Annual | March 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | April 1, 1999 |
| Public Since | March 18, 2004 |
| No. of Shareholders: | 4,880 |
| No. of Employees: | 32 |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | |
| Exchange | Tokyo Stock Exchange |
| Shares in Issue | 5,789,563 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 5F Suzue Baydium 1-15-1 Kaigan, MINATO-KU, 105-0022, Japan |
| Web | https://www.dna-chip.co.jp/ |
| Phone | +81 3 57771700 |
| Contact | Kenji Watanabe (Director of Accounting) |
| Auditors | Seiyo Audit Corporation |
As of 12:10am, shares in DNA Chip Research Inc are trading at ¥689, giving the company a market capitalisation of £26.3m. This share price information is delayed by 15 minutes.
Shares in DNA Chip Research Inc are currently trading at ¥689 and the price has moved by 8.43% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the DNA Chip Research Inc price has moved by -19.88% over the past year.
Of the analysts with advisory recommendations for DNA Chip Research Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for DNA Chip Research Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.
DNA Chip Research Inc is scheduled to issue upcoming financial results on the following dates:
DNA Chip Research Inc does not currently pay a dividend.
DNA Chip Research Inc does not currently pay a dividend.
DNA Chip Research Inc does not currently pay a dividend.
To buy shares in DNA Chip Research Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in DNA Chip Research Inc are currently trading at ¥689, giving the company a market capitalisation of £26.3m.
Here are the trading details for DNA Chip Research Inc:
Based on an overall assessment of its quality, value and momentum, DNA Chip Research Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for DNA Chip Research Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DNA Chip Research Inc. Over the past six months, the relative strength of its shares against the market has been -31.8%. At the current price of ¥689, shares in DNA Chip Research Inc are trading at -13.47% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for DNA Chip Research Inc.
DNA Chip Research Inc's management team is headed by:
Here are the top five shareholders of DNA Chip Research Inc based on the size of their shareholding:
